Why Yale UrologyAt Yale Urology, we understand that a diagnosis of bladder cancer can profoundly impact your life and leave you and your loved ones with many questions about your journey ahead. Our team is dedicated to providing the compassionate care, support, and information you need to move forward confidently with your treatment process.
Improved Detection of Bladder Cancers with Cysview
Smilow Cancer Hospital at Yale-New Haven recently became the only hospital in the state to offer Blue Light Cystoscopy with Cysview, which has been proven to significantly increase the detection of bladder cancer over white-light cystoscopy alone. 20.7% of patients with primary bladder cancer had at least 1 tumor detected with blue light that was not detected with white light. 27.7% of patients with recurrent bladder cancer had at least one tumor detected with blue light that was not detected with white light and a 7 month improvement in time to recurrence has been demonstrated.
Please consider referring your patients with known or suspected bladder cancer to have a Blue Light Cystoscopy with Cysview through the Prostate and Urologic Cancers Program at Smilow Cancer Hospital. Following diagnosis, the multidisciplinary bladder cancer program offers complete care with specialized pathology, neoadjuvant therapy options, an enhanced recovery after surgery (ERAS) protocol that has been demonstrated to reduce the length of stay and post-surgical complications, and advanced surgical techniques to maintain sexual function and bladder control.
Learn more about Cysview here.
Innovative MethodsYale Urology surgeons are at the forefront of cancer research, driving the search for new treatments and cures and staying current on the most advanced and effective techniques. We continually integrate the latest in science-based medicine and innovative approaches into our practice to offer patients safer and more effective treatments.
About Bladder CancerBladder cancer is the formation of malignant cells originating in the tissue lining the bladder or the urothelium. Bladder cancer is the fourth most common cancer in men and the eighth most common cancer in women. There are three types of bladder cancer:
- Transitional cell carcinoma – Transitional cell carcinoma originates from the bladder’s inner lining or urothelium and is the most common form of bladder cancer.
- Squamous cell carcinoma – This type of bladder cancer involves the thin, flat cells of the bladder. This form of bladder cancer is not as common in the United States.
- Adenocarcinoma – Adenocarcinoma originates in the cells that release mucus and other fluids. It can also originate from remnants of the umbilical cord.
Additional information about bladder cancer: